A Phase 1 First-in-Human Single Ascending-dose Study With a Novel Antibody to the Human Thymic Stromal Lymphopoietin Receptor

被引：0
|
作者：
Deykin, A. [1 ]
Brinkman, C. [1 ]
Lloyd, P. [2 ]
Becker, O. [1 ]
机构：
[1] Upstream Bio, Waltham, MA USA
[2] KinDyn Consulting Ltd, Warnham, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3013
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Multiple Ascending-dose Study With Verekitug, A Novel Antibody to the Human Thymic Stromal Lymphopoietin Receptor, in Adults With Asthma
    Singh, D.
    Deykin, A.
    Lloyd, P.
    Nestorov, I.
    Kalra, A.
    Biswas, S.
    Sinha, A.
    Brickman, C.
    Becker, O.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [2] ASP7266, a Novel Antibody against Human Thymic Stromal Lymphopoietin Receptor for the Treatment of Allergic Diseases
    Numazaki, Mako
    Abe, Masaki
    Hanaoka, Kaori
    Imamura, Emiko
    Maeda, Masashi
    Kimura, Akihiko
    Miyanohara, Jun
    Saito, Tetsu
    Arai, Kazunori
    Suzuki, Hiroshi
    Saita, Yuji
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2022, 380 (01): : 26 - 33
  • [3] A First-in-Human Phase 1 Randomized Single and Multiple Ascending Dose Study of RPh201 in Healthy Volunteers
    Hazan, Zadik
    Adamsky, Konstantin
    Lucassen, Andre
    Levin, Leonard A.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (03): : 366 - 374
  • [4] A First-in-Human Single Ascending Dose Study of GSBR-1290, a Novel Small Molecule GLP-1 Receptor Agonist, in Healthy Volunteers
    Coll, Blai
    Zhang, Jinqiang J.
    Jacober, Scott J.
    Argent, Christopher
    Ibarra, Lani
    Snyder, Margo
    Bach, Mark A.
    DIABETES, 2023, 72
  • [5] Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Human Monoclonal Antibody TQC2731 Targeting Thymic Stromal Lymphopoietin in Healthy Adults: A First-in-human, Randomized, Placebo-controlled, Double-blind, Phase 1 Study
    Tian, Xin
    Zhang, Xiaojian
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB20 - AB20
  • [6] Expression analysis and specific blockade of the receptor for human thymic stromal lymphopoietin (TSLP) by novel antibodies to the human TSLPRα receptor chain
    Borowski, Andreas
    Vetter, Tina
    Kuepper, Michael
    Wohlmann, Andreas
    Krause, Sebastian
    Lorenzen, Thomas
    Virchow, Johann Christian
    Luttmann, Werner
    Friedrich, Karlheinz
    CYTOKINE, 2013, 61 (02) : 546 - 555
  • [7] A novel monoclonal antibody against human thymic stromal lymphopoietin for the treatment of TSLP-mediated diseases
    Shi, Lihua
    Yu, Mingcan
    Jin, Ying
    Chen, Peng
    Mu, Guangmao
    Tam, Susan H.
    Cho, Minseon
    Tornetta, Mark
    Han, Chao
    Fung, Man-Cheong
    Chiu, Mark L.
    Zhang, Di
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [8] A phase 1, first-in-human single ascending dose study of the MEK inhibitor WX-554 given to healthy subjects.
    Mala, C.
    Neville, N. G.
    Haindl, E.
    Buergle, M.
    Schmalix, W.
    Bevan, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] 32-week data from a multiple ascending-dose study with verekitug, a novel antibody to the human TSLP receptor (TSLPR), in adults with asthma
    Deykin, Aaron
    Brinkman, Chaim M.
    Lloyd, Peter
    Nestorov, Ivan
    Kalra, Ashish
    Biswas, Subhabrata
    Sinha, Arkadeep
    Sivapalasingam, Sumathi
    Becker, Oren
    Singh, Dave
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [10] Functional characterisation of two receptor interaction determinants in human thymic stromal lymphopoietin
    Markovic, Iva
    Wolfrum, Therese
    Wohlmann, Andreas
    Gautam, Kritan
    Friedrich, Karlheinz
    BIOLOGICAL CHEMISTRY, 2022, 403 (02) : 243 - 249
12345